259 related articles for article (PubMed ID: 17202146)
1. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis.
Aguado T; Carracedo A; Julien B; Velasco G; Milman G; Mechoulam R; Alvarez L; Guzmán M; Galve-Roperh I
J Biol Chem; 2007 Mar; 282(9):6854-62. PubMed ID: 17202146
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez C; de Ceballos ML; Gomez del Pulgar T; Rueda D; Corbacho C; Velasco G; Galve-Roperh I; Huffman JW; Ramón y Cajal S; Guzmán M
Cancer Res; 2001 Aug; 61(15):5784-9. PubMed ID: 11479216
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C; Salazar M; Carracedo A; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Cancer Res; 2008 Mar; 68(6):1945-52. PubMed ID: 18339876
[TBL] [Abstract][Full Text] [Related]
5. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
De Jesús ML; Hostalot C; Garibi JM; Sallés J; Meana JJ; Callado LF
Neurochem Int; 2010; 56(6-7):829-33. PubMed ID: 20307616
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid Signaling in Glioma Cells.
Ellert-Miklaszewska A; Ciechomska IA; Kaminska B
Adv Exp Med Biol; 2020; 1202():223-241. PubMed ID: 32034716
[TBL] [Abstract][Full Text] [Related]
7. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
Palazuelos J; Aguado T; Egia A; Mechoulam R; Guzmán M; Galve-Roperh I
FASEB J; 2006 Nov; 20(13):2405-7. PubMed ID: 17015409
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
Widmer M; Hanemann CO; Zajicek J
J Neurosci Res; 2008 Nov; 86(14):3212-20. PubMed ID: 18615640
[TBL] [Abstract][Full Text] [Related]
9. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
[TBL] [Abstract][Full Text] [Related]
10. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid signaling in glioma cells.
Ellert-Miklaszewska A; Ciechomska I; Kaminska B
Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C; González-Feria L; Alvarez L; Haro A; Casanova ML; Guzmán M
Cancer Res; 2004 Aug; 64(16):5617-23. PubMed ID: 15313899
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid signaling in glioma.
Costas-Insua C; Guzmán M
Glia; 2023 Jan; 71(1):127-138. PubMed ID: 35322459
[TBL] [Abstract][Full Text] [Related]
14. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
16. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
Br J Cancer; 2009 Sep; 101(6):940-50. PubMed ID: 19690545
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid signalling.
Demuth DG; Molleman A
Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
